BACKGROUND
During the Ebola virus outbreak in West Africa in 2014-2016, health care workers (HCWs) were almost 30 times more likely to become infected with Ebola virus compared with non-HCWs. More than 800 HCWs contracted the disease, and more than 500 died. 1 One of the most important factors in protecting HCWs from Ebola virus and other viral hemorrhagic fevers is the availability of personal protective equipment (PPE), as well as proper training to appropriately put on (don) and take off (doff) that equipment. 2 For example, in a survey of returning HCWs to the United Kingdom, 8% reported direct contact with patients with confirmed Ebola virus disease (EVD) while not wearing PPE. Even with proper training and equipment, up to 17% of HCWs reported an intermediate-to high-risk exposure while providing care for patients with EVD. Intermediate risk was defined as potential contact of mucous membranes or broken skin with bodily fluids of a patient with EVD. High risk was defined as definite exposure of mucous membranes or broken skin with the bodily fluids of a patient with EVD (eg, a needlestick injury through visibly soiled gloves). 3 Some HCWs became infected without a known exposure, raising further questions about the effectiveness of current PPE and PPE protocols. 4 The doffing process is believed to be a particularly high-risk time in terms of self-contamination and subsequent infection. Hand hygiene and the removal of powered air-purifying respirator hoods have perhaps the highest level contamination risk. [5] [6] [7] [8] In response to the recognized need to improve current PPE, the Johns Hopkins University Center for Bioengineering Innovation and Design (CBID) and Jhpiego, an international nongovernmental organization affiliate of Johns Hopkins University, organized the "Johns Hopkins Emergency Ebola Design Challenge" in October of 2014, with support from Clinvue, a health care design consultancy. During this weekend hackathon, a spiral model design process was used to create innovative features for a novel PPE design. 9, 10 More than 80 individuals from multiple disciplines (eg, engineering, fashion design, infection control) participated in the event. The top challenges with standard M edecins Sans Fronti ere (MSF) Ebola PPE were identified, and the team chose the most feasible and impactful challenges on which to focus. These included fogging of eye protection, difficulty with HCW identification and communication, comfort, and the complexity of the doffing process. The design process centered on 4 key elements, including clinical performance, technical performance, commercialization potential, and team organization. The best design elements from the challenge were incorporated into a single PPE ensemble. A combined team from CBID and Jhpiego then traveled to West Africa multiple times to gain feedback on all elements of the design from frontline HCWs. More than 200 HCWs from both West Africa and the United States provided comments on the ensemble. Each change to the ensemble was tested by HCWs who would potentially wear the suit. The PPE was also subjected to technical evaluations and critical vetting from experts in the PPE industry, global health, and programmatic implementation.
In this study, HCWs in a mock Ebola treatment center (ETC) in Liberia and a US biocontainment unit compared standard MSF PPE (PPE A) to the new CBID/Jhpiego PPE (PPE B) to test the comfort, ease of doffing, perception of risk, and preferences for each PPE ensemble.
METHODS

MSF PPE ensemble (PPE A)
The MSF PPE ensemble includes a coverall or gown, a hood to cover the head, goggles to protect the eyes, a surgical mask or N95 respirator for the nose and mouth, a double layer of gloves, rubber boots, and an outer apron (Fig 1) . 9, 11 CBID/Jhpiego PPE ensemble (PPE B)
The main design innovations featured in the final CBID/Jhpiego PPE include a rear zipper protected by a rigid double flap, finger loops to secure gloves and protect hands and wrists from contamination, a high neck collar, and doffing tabs that are secured to the shoulder. These tabs are used during the doffing process and allow the user to pull the coverall off while folding the contaminated outside of the suit into itself. 9 These features were designed to improve the ease of doffing, as well as the comfort and safety of the provider. The initial design also included a hood with an integrated facemask and isolated inhalation and exhalation pathways to provide head coverage, respiratory protection, infusion of fresh air, and reduction in fogging. The design process of the hood, mainly to reduce cost, is still ongoing within CBID and DuPont. The remainder of this manuscript focuses only on the coverall component of the novel design (Fig 2) .
Study location and participants
Once the final CBID/Jhpiego design was completed, the study team identified 2 sites to compare the usability of standard MSF Ebola PPE (PPE A) to the novel coverall (PPE B). The first site was a conference room of a private rented facility in Monrovia, Liberia. Many of the participants from the Liberian site were experienced with standard MSF PPE and had provided care for patients with EVD during the 2014-2016 outbreak. The second site was The Johns Hopkins Hospital (JHH) Biocontainment Unit (BCU) in Baltimore, Maryland. Participants at both sites were recruited through convenience sampling. In Liberia, participants were recruited via word of mouth, as well as posting of fliers at local health care facilities. In the United States, participants were recruited by emailing all rostered staff of the JHH BCU. All adult HCWs over the age of 18 were eligible for participation. The only exclusion criterion was exposure to a patient with known EVD in the 21 days before enrollment. Informed consent was obtained to participate in the study. Participants at each site were required to complete a respiratory assessment to ensure that they could safely wear each PPE ensemble. The study took place from June 14-17, 2016, in Liberia, and from June 28-July 15, 2016, in the Johns Hopkins BCU. Participants at the Johns Hopkins BCU did not receive any compensation or incentives for their involvement in the study. Participants in Liberia were reimbursed for transportation and meals on the day of the study.
Study protocol
At each study site, 5 stations were created to simulate clinical scenarios and test various elements of each PPE ensemble. Temperature and humidity were recorded at each site on the days of the study. Participants rotated through the 5 stations wearing 1 type of PPE and then repeated the same 5 stations wearing the second type of PPE. PPE A was worn first at each site, followed by PPE B. Because the majority of participants in Liberia were familiar with PPE A, the decision was made not to randomize the order of the PPE ensemble and to have participants complete tasks in PPE A first, in order to be able to then compare performance with PPE B. Stations 1, 4, and 5 focused specifically on the coverall and will be the focus of the remainder of this article.
Station 1 focused on the donning process. Each participant donned appropriate PPE with the assistance of a donning partner. After the donning process, study participants were asked questions about how the PPE they had just donned compared with their standard PPE ensemble. The donning protocol for PPE A is available at http://msf-seasia.org/ 16369. 11 The donning protocol for PPE B is available in the Appendix.
Station 4 assessed the comfort of PPE during routine use. Participants were asked to perform movements they might use while working in an ETC (eg, walking, squatting, bending over, lifting arms). They were also given specific activities to perform in PPE, including helping a mock patient to sit up, administering 2 tablets and a glass of water to the patient, and cleaning up simulated vomit. Participants were observed during these tasks and then self-reported their comfort while performing each activity.
Station 5 focused on the doffing process. Participants were observed while they doffed the 2 types of PPE. Each step of the doffing process was timed by an observer. Participants provided feedback on the doffing process related to the ease of doffing, as well as their perceived risk of self-contamination. The doffing protocol for PPE A is available at http://msf-seasia.org/16369. 11 The doffing protocol for PPE B is available in the appendix. After station 5, participants completed a final survey. The survey asked participants to rank order the novel features of PPE B. The survey also asked participants about their overall PPE preferences, including whether they would recommend PPE A or PPE B, and whether they thought it would be worth spending additional money on PPE B if the costs were higher.
Statistical analysis
The results at each station were compared for PPE A and PPE B within the Hopkins BCU and within the Liberian simulated setting. Comparisons were not made between the Hopkins and Liberian sites because the demographics and clinical experience across both sites with regard to EVD were different. Statistical significance was determined using Fisher's exact, x 2 , and Mann-Whitney U tests on R statistical software (Free Software Foundation, Inc., Boston, MA). Values were considered statistically significant at P < .05.
Ethical approval
Ethical oversight was provided by the Johns Hopkins University School of Medicine institutional review board (Protocol no. 00080031) and the National Research Ethics Board, Ministry of Health, Liberia (Protocol NREB-004-16).
RESULTS
Conditions at each study location
Average temperature and humidity levels in Monrovia over the course of the study were 81.6°F and 80.3%, respectively, whereas temperature and humidity levels at the JHH BCU in Baltimore were below 70°F and 50%.
Baseline characteristics of the study population
Thirty-four participants enrolled in Liberia, and 20 participants enrolled in Baltimore (Table 1 ). All participants completed the study wearing both PPE ensembles. Each participant spent approximately 6-8 hours completing the protocol.
The 2 populations were almost equally split between males and females. The median age of the participants was 30-39. However, there was a slight difference in the age distribution, with more participants over 50 years of age in the JHH BCU group. Although the BCU participants were split between clinicians and nonclinicians (nonclinicians include trained clinical laboratory staff and paramedics), two-thirds of the Liberia participants were clinicians who cared for patients with EVD during the 2014 outbreak. None of the JHH BCU participants had provided care for patients with EVD during the outbreak. Standard doffing procedures differed between sites. Eighty percent of participants in the BCU reported using a doffing partner as part of their standard doffing procedure, compared with only 32.3% of Liberia participants. The Liberia participants had more experience (79.4%) with the MSF PPE (PPE A) than the BCU participants (26.3%).
Comfort while wearing each PPE ensemble
Participants were asked to undergo a simulated situation that might occur while caring for patients with EVD. Their comfort levels were recorded in both PPE A and PPE B (Table 2 ). Any indication of discomfort, even minor, was counted as discomfort. The 2 sites were compared independently as indicated above. BCU participants were significantly more comfortable while walking in PPE B compared with in PPE A (94.7% vs 50%, P = .0033). The overall trend was for more comfort in PPE B during all types of movements across both sites.
The doffing process
Participants were asked for feedback on the doffing process. PPE B had novel doffing pull tabs that the majority of participants at both sites felt were intuitive to use. The majority of the participants at both sites also believed that doffing PPE B would be feasible in an ETC. Participants at both sites felt significantly more at risk while doffing PPE A compared with PPE B. In Liberia, where the majority of the participants had worn PPE A while treating patients with EVD, 71.9% reported feeling at risk in PPE A, whereas only 25% reported feeling at risk in PPE B (P < .0001). One hundred percent of BCU participants reported feeling at risk in PPE A, whereas 40% felt at risk in PPE B (P < .0001) ( Table 3) . Much of the perceived risk in PPE A revolved around concerns that the face and neck area might become contaminated while removing the coverall. Most concerns about PPE B centered around the possibility that the inner glove would come off with the outer suit and lead to hand contamination. Despite the self-doffing tabs, 20%-25% of participants in both groups believed they would still need a partner to doff PPE B. Several individuals at both sites were concerned that reaching for the self-doffing tabs without a mirror might lead to contamination.
Time to doff the apron, outer gloves, coverall, and inner gloves were measured for PPE A, and the time to doff the apron, first hand, second hand, and stomping out of PPE were measured for PPE B. BCU participants doffed PPE B almost 2 minutes more quickly than PPE A (4:35 vs 6:45, P = .0815). In Liberia, participants doffed PPE A in a shorter amount of time than PPE B (6:41 vs 7:07, P = .6786).
PPE preference
At the end of the study, participants were asked questions about their PPE preferences (Table 4) .
In all cases and across both sites, participants significantly preferred PPE B for donning, doffing, removal of outer gloves, and the overall experience. Moreover, participants at both sites said they would recommend PPE B for their facility even if the cost was greater (Table 5) . Participants were also asked to rank the features of the PPE B with a numerical value from best to worst. The rear entry and exit seam, rear zipper with secured flap and adhesive, and the over-the-shoulder pull-tabs were ranked roughly equally as the best features among the participants from both Liberia and the BCU ( Table 5 ). The finger loops were consistently ranked as the worst feature both in Liberia and the BCU. Several users felt that the finger loops were constricting and made it difficult to get the outer gloves off.
DISCUSSION
This study shows that a novel PPE coverall with unique design features was preferred over traditional MSF PPE in terms of comfort and perception of risk. Participants in Liberia, as well as at a biocontainment unit in the United States, overwhelmingly preferred the novel PPE design and would recommend it for their facility even if it cost more than their current PPE. The novel PPE was preferred during both donning and doffing and took less time to doff than MSF PPE among users who had not previously used either style of PPE. Although the time to doff a PPE ensemble is not a marker of safety, the fact that the novel PPE ensemble did not take longer to doff than standard PPE suggests that the new ensemble would not place an unreasonable time burden on HCWs. The rear entry and exit seam, the covered zipper, and the over-the-shoulder pull tabs were the most highly rated aspects of the design. The unique finger loops that aid in removing the outer glove were the least highly rated aspect of the design but were more highly rated by providers in Liberia than in the JHH BCU.
This study suggests that features designed to improve the ease of the doffing process are favored by HCWs in the context of highly infectious diseases. The over-the-shoulder tabs in PPE B allow a provider to potentially self-doff the PPE ensemble without having to rely on the assistance of a partner during this critical step. This feature was particularly attractive to providers in Liberia who often use protocols that lack a doffing assistant. The rear entry and covered zipper were also attractive features to both groups. This was possibly owing to the known risk of contamination of the chest area of PPE, even while wearing an outer apron. 5 There are a number of limitations to this study. There was a difference in clinical experience between the US and Liberian providers in terms of actual clinical care of patients with high-consequence pathogens. Liberian providers were more likely to have provided care for patients with EVD and had more experience with PPE A before the study. This difference in experience probably affected participants' views of the 2 PPE ensembles. However, the fact that Liberian clinicians with experience in providing care for patients with EVD . Median time to doff is reported and comparison by time is done using a Mann-Whitney U test. *Statistical significance (P < .05). preferred PPE B suggests that the novel design features were an improvement over existing PPE options. Differences in heat, fogging, and the amount of time an HCW is able to comfortably remain in PPE may be partly attributed to differences in temperature and humidity between Monrovia and Baltimore. Other factors, such as the availability of human resources at each location, also influence donning and doffing protocols for HCWs. These differences likely affected participants' opinions of the 2 PPE ensembles.
The PPE CBID/Jhpiego PPE ensemble tested in this study included a hood with an integrated respirator. That aspect of the design is still under development. It is unclear whether the use of the integrated hood in the current experiment influenced the overall opinions of HCWs in favor of the CBID/Jhpiego PPE.
Participants at both sites felt safer in PPE B and would recommend its use independent of cost. However, perceptions of risk do not always match objective measures of performance. 13 Further studies are needed to evaluate whether the risk of contamination is truly lower using PPE B. We are in the process of optimizing a protocol that uses fluorescent microbeads to track simulated infectious particles through a clinical space during HCW activities. This method has been used to test the air-handling and environmental safety features of the JHH BCU and is currently being modified to be able to detect HCW contamination, particularly during the doffing process. This could provide safety data to better understand the potential advantages of PPE B compared with PPE A.
14 PPE A was tested first at both sites. The lack of randomization of PPE order in the study protocol may have introduced unintended biases toward one of the PPE ensembles.
Although most providers across both sites indicated they would pay more for the CBID/Jhpiego PPE, we were unable to conduct specific cost analyses to compare the price difference of standard MSF PPE with the CBID/Jhpiego PPE. After the study was completed, Johns Hopkins University licensed both the coverall and hood PPE design patents to DuPont, a leader in the production of PPE and materials such as Tyvek and Tychem that are routinely used in PPE. DuPont has placed these new PPE designs in their internal product development process. Market and commercialization factors, including improved value and performance of the new design, cost to manufacture, costs associated with the recent increased involvement of the US Food and Drug Administration in regulating PPE, and market demand, all impact the timeline for large-scale availability of these new designs in the market.
CONCLUSIONS
A new PPE coverall designed to improve comfort and ease of the doffing process was preferred over MSF PPE by HCWs in Liberia and in a US BCU. An iterative-spiral health care design process effectively identified problem areas with current PPE and directed the design team to innovative solutions. HCWs felt more comfortable and safer in the new PPE and would recommend its use in their home units, even if it cost more than standard PPE. Further studies are needed to address the efficacy of this design in preventing HCW infection when providing care for patients infected with high consequence pathogens. (Continued) Steps for donning newly designed coverall
Step 7: Bend forward with head below the shoulder level.
Step 8: Remove the hood by pulling the rubber band of the mask away from the head so that both hood and the mask come out as a single piece.
Step 9: Let the hood and mask fall on the floor.
Step 10: Immediately after removing the hood, disinfect the inner gloves with 0.5% chlorine solution or ABHR.
Step 11: Gently lift the hood off the floor and dispose of it in a contaminated waste container.
Step 12: Disinfect the inner gloves with 0.5% chlorine solution or ABHR.
ABHR, alcohol-based hand rub.
